Stop the dry eye vicious cycle of inflammation for your dry eye patients! OptiLight, the first FDA-approved light therapy for dry eye disease has the potential to: 👏 Decrease the level of pro-inflammatory mediators to inhibit inflammation 👏 Significantly boost tear breakup time and decrease osmolarity 👏 Destroy the abnormal blood vessels that perpetuate inflammation 👏 Improve meibomian gland morphology and functionality 👏 Decrease population of Demodex mites which stimulate infection Learn

Doctors, your patients don't have to just live with dry eyes. Meet OptiLight, the first and only light therapy for dry eyes. | Lumenis Vision